Researchers in the U.K. have found that an estrogen patch is an effective way to treat prostate cancer compared with side effects-laden hormone injections and pills.
Phosphagenics' 72-hour oxymorphone transdermal patch is set to enter the clinic next month, in a Phase I trial in Australia's Royal Adelaide Hospital. Results are expected as early as March.
With the headache of a previous FDA rejection behind it, NuPathe finally gained the agency's approval for its migraine patch, Zecuity, a battery-powered delivery system designed to get a tried-and-true drug into the bloodstream.
Agile Therapeutics has snagged a term loan facility for up to $15 million from Oxford Finance to help push forward its pipeline of contraceptive patches in clinical and preclinical development.
In a Phase III trial of Agile Therapeutics' combination contraceptive patch, AG200-15, women were much less likely to miss days of contraception with the patch than with the birth control pill.
Zosano Pharma has revealed a potentially lucrative new use of its transdermal patch technology, through a deal with Asahi Kasei Pharma (AKP) to develop the Freemont, CA-based firm's patches for
Struggling biotech Intercell isn't giving up on its needless patch system for delivering vaccines. After its vax patch flunked multiple trials last year, the Austria-based firm is on the hunt for new
For decades fenretinide has been an anti-cancer agent without a home. This synthetic derivative of Vitamin A has, until now, not performed too well in the body, with complications including low
Scientists say that problems with injected treatments for peripheral artery disease (PAD) could be solved by a skin patch hooked up to a battery. Caused by blocked arteries in the leg, PAD can be
Viagra delivered via a patch with nanocarriers might work better than the blue pill for erectile dysfunction, according to researchers in Egypt. While oral delivery does work, there is too long a